Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1989 2
1990 2
1991 4
1992 2
1993 1
1994 3
1996 1
1997 3
1998 3
1999 2
2000 8
2001 8
2002 15
2003 16
2004 19
2005 17
2006 12
2007 13
2008 14
2009 24
2010 20
2011 20
2012 21
2013 21
2014 27
2015 18
2016 21
2017 28
2018 31
2019 29
2020 22
2021 24
2022 22
2023 21
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Thompson AJ, et al. Among authors: uitdehaag bmj. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275977 Review.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators. Lublin F, et al. Among authors: uitdehaag bmj. Lancet. 2016 Mar 12;387(10023):1075-1084. doi: 10.1016/S0140-6736(15)01314-8. Epub 2016 Jan 28. Lancet. 2016. PMID: 26827074 Free article. Clinical Trial.
Biomarker time out.
Petzold A, Bowser R, Calabresi P, Zetterberg H, Uitdehaag BM. Petzold A, et al. Among authors: uitdehaag bm. Mult Scler. 2014 Oct;20(12):1560-3. doi: 10.1177/1352458514524999. Epub 2014 Feb 20. Mult Scler. 2014. PMID: 24557857 Review.
Finding suggest spondylodiscitis.
Algra PP, Uitdehaag BM. Algra PP, et al. Among authors: uitdehaag bm. J Fla Med Assoc. 1991 Dec;78(12):839-40. J Fla Med Assoc. 1991. PMID: 1774563 No abstract available.
Multiple sclerosis: current knowledge and future outlook.
Kamm CP, Uitdehaag BM, Polman CH. Kamm CP, et al. Among authors: uitdehaag bm. Eur Neurol. 2014;72(3-4):132-41. doi: 10.1159/000360528. Epub 2014 Jul 30. Eur Neurol. 2014. PMID: 25095894 Free article. Review.
Outcome Measures in Clinical Trials for Multiple Sclerosis.
van Munster CE, Uitdehaag BM. van Munster CE, et al. Among authors: uitdehaag bm. CNS Drugs. 2017 Mar;31(3):217-236. doi: 10.1007/s40263-017-0412-5. CNS Drugs. 2017. PMID: 28185158 Free PMC article. Review.
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis.
Rodriguez-Mogeda C, van Lierop ZYGJ, van der Pol SMA, Coenen L, Hogenboom L, Kamermans A, Rodriguez E, van Horssen J, van Kempen ZLE, Uitdehaag BMJ, Teunissen CE, Witte ME, Killestein J, de Vries HE. Rodriguez-Mogeda C, et al. Among authors: uitdehaag bmj. J Neuroinflammation. 2023 Sep 26;20(1):215. doi: 10.1186/s12974-023-02900-z. J Neuroinflammation. 2023. PMID: 37752582 Free PMC article.
The role of the cerebellum in multiple sclerosis-150 years after Charcot.
Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group. Parmar K, et al. Among authors: uitdehaag bmj. Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Neurosci Biobehav Rev. 2018. PMID: 29477616 Review.
421 results